The pharmaceutical wholesaler Celesio has worried investors with a bond of EUR 350 million for new capital.
The Stuttgart company on Wednesday placed a corresponding bond maturing in October 2016, Celesio has announced. The bond has a term of four years and a fixed coupon of 4.0 percent. Through denominations of EUR 1,000, Celesio is offering both institutional investors and retail investors the opportunity to participate in the bond.
The money will be used for corporate financing. „These include, for example, the repayment of bank debt, the repayment of maturing debt in the coming years, and investment in business operations,“ said CFO Marion Helmes.
Indeed, the group had posted a loss of EUR 184 million in the first half due to high depreciation of various daughter companies.
[ilink url=“http://www.celesio.com/de/Presse/Pressemitteilungen/Pressemitteilungen_Konzern/306370.html“] Link zur Quelle (Celesio)[/ilink]